FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2026
Back to search
Official data from USPTO
RESEARCH PIECES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
07/28/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
11/30/2022
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
07/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
FR
Examiner
DERBY, KAREN SHEREE
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the following: a stylized brain in light blue overlapped by stylized gears and microorganisms in light blue, dark blue and orange shapes with the words "RESEARCH" in dark blue underneath and "PIECES" in smaller stylized orange text under the word "RESEARCH".
Holders and representatives
Holders
R. P. (pessoa física)
Representatives
Michelle P. Ciotola Cantor Colburn LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biologicalbiochemical and chemical preparations for use in industryscience and for scientific purposes other than for medical or veterinary use; biological preparations for use in cell cultures other than for medical or veterinary use; stem cells for research purposes; stem cells for sciencefor scientific purposes; biological microorganisms other than for medical or veterinary use; cultures of microorganisms other than for medical or veterinary use ; cultures of microorganisms and cell media cultures other than for medical or veterinary use; biological tissue from different organsnamely from rodentprimate and human biopsy and cell media culturesother than for medical or veterinary use; cultures of microorganisms for industrial useother than for medical or veterinary use; cell culture media for laboratory use; cell culture media for use in non-medical research laboratories and in the biotechnology industry; cell growth media for cell culture for use in scientific research; solutions for non-medical scientific use for storing and preserving human organs; chemical compositions for scientific and industrial use for the preparation of culture media; biochemicals for in-vitro and in-vivo scientific use; chemical for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; chemical laboratory preparations for scientific purposesother than for medical or veterinary use ; preservatives for the viability of micro-organisms in cultures for pharmaceutical industrial use; biological preparations other than for medical and veterinary use; bacterial preparations for scientific and industrial use; chemical preparations for analyses in laboratoriesother than for medical or veterinary use; chemical preparations for pathological examinationsother than for medical and veterinary use; chemical preparationsbiochemical preparationsreagentschemical reagents and diagnostic preparations for scientific or research use other than for medical or veterinary use; diagnostic reagents for in-vitro use other than for medical usein vivo for scientific usein-vitro use for biochemistryclinical chemistry and microbiology; reagents for in-vitro use in laboratories other than for medical or veterinary use; cell culture reagents for scientific use and for research; reagents for chemical and microbiological analysis other than for medical or veterinary use; test reagents for scientific or industrial use other than medical use; chemical reagents for use in scientific fieldfor molecular biology and for biotechnology other than for medical or veterinary use; chemical preparations used for analysisreagents for analytical tests and diagnostic tests for biological treatment other than for medical or veterinary use
Class 5
Biologicalchemicalbiochemical preparationsantibodiesantiviral substancesantibioticsanticancer substancesagentsmoleculesreagents for medical and pharmaceutical use for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorderscancer; chemical and biochemical products for pharmaceutical use for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; chemico-pharmaceutical products for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; pharmaceutical products for the prevention and treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; pharmaceutical productsagents or molecules targeting neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; pharmaceutical products for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer for use in organ transplant; organotherapy preparations; chemical and biological reagents for medical use for analyses for medical use; reagents for in vitro use in laboratories for medical use; reagents for use in genetic testing and medical diagnostic testing; diagnostic chemical reagents for medical use; reagents for chemical and microbiological analyses for medical use; immunological reagents for medical use; biological preparations from tissuesorgansbiochemicalbiotechnological and chemical preparations for medical use for analyses and treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; chemical preparations for medical use for blood analysis of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; preparations of micro-organisms for medical use for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; chemical-pharmaceutical preparations for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; pharmaceutical preparations for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; pharmaceutical preparations and substances for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; pharmaceutical preparations for tissue regeneration for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; pharmaceutical preparations containing stem cells for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; pharmaceutical preparations for human use for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; pharmaceutical preparations for activating cellular function for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; diagnostic in vitro preparation for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; living cells for medical use; stem cells for medical use; stem cells for use in cell and gene therapies for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; pharmaceutical compositions containing stem cells for the treatment of neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; culture media for biological tissue grafts or implants comprising living tissue; bacteriological culture media and culture media for bacteriology for medical use; cell growth media for growing cells for medical use; cell culture media for biological tissue graftsimplants comprising living tissue; cultures for biological tissue graftsimplants comprising living tissue and stem cell therapy; biological tissue cultures for medical use; cultures of micro-organisms for graftsimplants and stem cells in neurodegenerativeinflammatoryinfectious and viral diseasesimmune and metabolic disorders or cancer; blood for medical purposes; surgical implants comprised of living tissues obtained from stem cells; biological neuralskin tissues for implantation and transplantation; grafts in the nature of skin graftsarterial graftsbiotechnical tissue grafts; arterial grafts; vascular grafts in the nature of living tissue; skin grafts; biological implants and implantsnamely cells culturestem cellstissues for pharmaceutical use; implants comprising living tissues for guided tissue regeneration; surgical implants comprised of living tissuesgrown from stem cells; human tissue for allografts; processed human donor skin for the replacement of soft tissue and biological tissue culture for medical use; human growth hormones; vaccines for human use; viral vaccines
Class 42
Scientifictechnological and biotechnological servicesnamely analysistestsdesignadvices and studies in the field of neurosciencescancergeneticsepigeneticsmicrobiology and viruses; pharmaceutical product evaluation in the nature of conducting scientific studies and tests on pharmaceutical products; scientific laboratory services; biological and medical research laboratory services; chemical research laboratory services; pharmaceutical research and development services in the field of cytologychemistrygene expression systemsengineeringbiotechnologyphysics and medical field; pharmaceutical research and development services in the field of vaccines; pharmaceutical product development services; scientific research services for medical purposes concerning all pathologies; biochemical research services; drug discovery services; DNA screening services for scientific research; biological cloning services; biochemical engineering; chemical engineering; genetic engineering services in the nature of advisory and technical consulting in the fields of neurosciencescancergeneticsepigeneticsmicrobiology and viruses; microbiological testing services in the nature of fluids analysisblood analysiscerebrospinal fluid analysisurine analysis; scientific research services with respect to the isolation and cultivation of human cellsof tissues; biotechnology product testingtechnical product testing and pharmaceutical product testing services; product testing in the nature of services for assessing the efficiency of pharmaceutical products and industrial chemicals; blood analysis services for scientific research purposes; providing information relating to scientific research; consulting services in the fields of neurosciencescancergeneticepigeneticsmicrobiologyviruses and vaccine research; advisory services and technical consulting in the fields of neurosciencescancergeneticepigeneticsmicrobiologyviruses and vaccine research; advisory services with respect to gene therapy research; advisory services with respect to research and development in the field of therapeutics and biotechnology; advisory services in engineering and with respect to biochemistry; advisory services with respect to scientific laboratory services; consulting services in the field of pharmaceutical research and development; consulting services in the field of information technology for the pharmaceutical and health industries; consulting services in the field of biology and pharmaceutical research and development; medicalbiomedicalpharmaceutical and pharmacological research services; chemical research and analysis services; laboratory research services relating to pharmaceutical products; laboratory research in the field of biotechnology and chemistry; biological research; pharmaceutical research services; technology research in the field of neurosciencescancergeneticepigeneticsmicrobiologyviruses and vaccine; biotechnology research; research in the field of neurosciencescancergeneticepigeneticsmicrobiologyviruses and vaccine; research in the field of chemistry; research in the field of biochemistry; scientific research in the field of genetics; scientific research in the field of molecular sciencegenetic engineeringgene therapypharmaceuticals and pharmacogenetics; scientific research for medical purposes concerning all pathologies; biological and medical research; clinical research in the field of neurosciencescancergeneticepigeneticsmicrobiologyviruses and vaccine; biological and biochemical research and analysis; research and development of productsnew productsvaccines and medicines; scientificbiotechnologicalbiochemical research and development for the pharmaceutical industry; research and development in the field of diagnostic preparations; development of pharmaceutical preparationsproducts and medicines; scientific research in the field of cell culture; scientific research in the field of stem cells; research and development in the field of stem cells; research services in the field of neurosciencescancergeneticepigeneticsmicrobiology and virusesbiological sample preparations for research purposesfor testing and analysis in research laboratories; tissue engineering; cultivation and engineering of cells and tissues for scientific and research purposesfor others; analysis in the field of molecular biology and technology engineering; medical research in the nature of analyses on human tissues and human serums; scientific research in the field of neurosciencescancergeneticepigeneticsmicrobiologyviruses and vaccineconducted using databases; medical research conducted using databases; technology research in the field of neurosciencescancergeneticepigeneticsmicrobiology and viruses provided by engineers testing new productschemical productsengineeringtoxicity for research purposes; genetic testing on laboratory animals for research purposes; design and testing in the framework of new product development; designing and developing engineering products; conducting engineering studies in the nature of preclinical molecules screeningclinical trialsvaccine engineering studiestherapeutics engineering studiesgenetics in the field of biochemistry and biotechnology; preparation of reports with respect to biotechnology; providing information relating to medical and scientific research information in the field of pharmaceuticalsclinical trials and scientific technology; providing information relating to scientific research and information services with respect to technological research; providing information relating to scientific research in the field of biochemistry and biotechnology
Publications
History of USPTO decisions and trademark events.
32 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
GPNX
NOTIFICATION PROCESSED BY IB
03/05/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/18/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/17/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/07/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/08/2025
GNFR
FINAL REFUSAL E-MAILED
04/08/2025
CNFR
FINAL REFUSAL WRITTEN
04/08/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/11/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/22/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/21/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/03/2024
RFNT
REFUSAL PROCESSED BY IB
12/19/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/29/2023
RFRR
REFUSAL PROCESSED BY MPU
11/29/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/28/2023
CNRT
NON-FINAL ACTION WRITTEN
11/27/2023
DOCK
ASSIGNED TO EXAMINER
09/09/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/26/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/27/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/24/2023
Continuous trademark protection
Get notified about every new filing that threatens RESEARCH PIECES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.